Progyny

Progyny

Yahoo Finance • yesterday

3 of Wall Street’s Favorite Stocks We Keep Off Our Radar

3 of Wall Street's Favorite Stocks We Keep Off Our Radar Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it's important to remain skeptical because analysts face... Full story

Yahoo Finance • 9 days ago

Q2 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks

Q2 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks Let's dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q2 health insurance providers earnin... Full story

Yahoo Finance • 12 days ago

The 5 Most Interesting Analyst Questions From Progyny’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From Progyny's Q2 Earnings Call Progyny's second quarter results were met with a negative market reaction, despite the company delivering revenue and non-GAAP profit above Wall Street expectations.... Full story

Yahoo Finance • 19 days ago

Why Progyny Stock Plunged, Then Gradually Recovered Today

Key Points Progyny's sales and adjusted earnings per share grew by 5% and 15% in the second quarter. However, management's conservative guidance for 7% to 11% revenue growth in Q3 worried the market. Ultimately, everything looked solid, a... Full story

Yahoo Finance • 20 days ago

Progyny Non-GAAP EPS of $0.55 beats by $0.03, revenue of $350.5M beats by $1.85M

* Progyny press release [https://seekingalpha.com/pr/20610907-progyny-inc-announces-second-quarter-2026-results] (PGNY [https://seekingalpha.com/symbol/PGNY]): Q2 Non-GAAP EPS of $0.55 beats by $0.03. * Revenue of $350.5M (+5.3% Y/Y) b... Full story

Yahoo Finance • last month

1 Cash-Producing Stock with Competitive Advantages and 2 Facing Challenges

1 Cash-Producing Stock with Competitive Advantages and 2 Facing Challenges Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effective... Full story

Yahoo Finance • last month

Progyny (PGNY) Stock May Be 50% Undervalued On Fresh Analyst Upgrades

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Progyny stock has climbed strongly in the near term and reached a fresh 52 week high, yet there is a clear split in what the valua... Full story

Yahoo Finance • 2 months ago

Q2 watchlist: Healthcare stocks with perfect EPS revision scores

[Heart Health Concept] Eoneren/E+ via Getty Images As Q2 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess demand across care delivery, diagnostics, life sciences, pharmaceuticals, medical... Full story

Yahoo Finance • 2 months ago

Progyny (PGNY): Buy, Sell, or Hold Post Q1 Earnings?

Progyny (PGNY): Buy, Sell, or Hold Post Q1 Earnings? Progyny trades at $31.10 per share and has stayed right on track with the overall market, gaining 13.4% over the last six months. At the same time, the S&P 500 has returned 9%. Is now... Full story

Yahoo Finance • 2 months ago

Progyny (PGNY) Earns Higher Price Target After Management Meetings

With EPS growth for the next five years forecasted at 40.83%, Progyny, Inc. (NASDAQ:PGNY) is among the 12 Best Quality Stocks to Buy and Hold for the Next Decade. On June 22, Truist raised its price target on Progyny, Inc. (NASDAQ:PGNY) t... Full story

Yahoo Finance • 2 months ago

Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks

Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks As the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the health insurance providers industry,... Full story

Yahoo Finance • 2 months ago

What Does the Sale of Progyny Shares by the CFO Mean for Investors?

Key Points CFO Mark Livingston sold 8,275 shares for a transaction value of ~$211,000 on May 20, 2026. This represented 9.47% of Livingston's direct holdings, reducing his direct position to 79,063 shares. The transaction involved only di... Full story

Yahoo Finance • 3 months ago

Progyny (PGNY) Authorizes $200M Share Repurchase Program

Progyny, Inc. (NASDAQ:PGNY) is one of the 15 Most Promising Stocks to Buy Right Now. On May 26, 2026, Progyny, Inc. (NASDAQ:PGNY) announced that its Board of Directors approved a share repurchase program to buy back up to $200 million of... Full story

Yahoo Finance • 3 months ago

A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000

Progyny(NASDAQ:PGNY) delivers fertility benefits to major employers; a key insider recently trimmed their stake, according to SEC filings. Kevin K. Gordon, Director at Progyny, reported the sale of 5,500 shares of common stock for a trans... Full story

Yahoo Finance • 3 months ago

Smart ring firm Ōura confidentially files for U.S. IPO (update)

[Wooden blocks with the word IPO and virtual stock graph. Initial Public Offering or stock launch concept.] fadfebrian Smart ring maker Ōura Health Oy, which competes with tech heavyweights such as Apple (AAPL [https://seekingalpha.com/sy... Full story

Yahoo Finance • 3 months ago

StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Guggenheim upgraded StubHub (STUB) to... Full story

Yahoo Finance • 4 months ago

Trump administration proposes easier employer access to IVF benefits

[Writing note showing Benefits. Business photo showcasing hike in allowance for senior employees of the company written on Wood Piece holding by man on the Blue Jeans background.] Artur/iStock via Getty Images The Trump administration sai... Full story

Yahoo Finance • 4 months ago

Progyny anticipates 2026 revenue of $1.365B-$1.405B while raising adjusted EBITDA to $232M-$244M

Earnings Call Insights: Progyny (PGNY) Q1 2026 MANAGEMENT VIEW * “We’re pleased to report that we’ve had a good start to the year with record first quarter revenue coming in at the higher end of our expectations. And net income, earnin... Full story

Yahoo Finance • 4 months ago

Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announces Progyny Select, the industry’s first fully insured, comprehensive supplemental fe... Full story

Yahoo Finance • 5 months ago

2 Reasons to Sell PGNY and 1 Stock to Buy Instead

Although the S&P 500 is down 2.1% over the past six months, Progyny’s stock price has fallen further to $17.17, losing shareholders 16.6% of their capital. This was partly driven by its softer quarterly results and might have investors con... Full story